Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy
- 1 February 2007
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 29 (2), 253-260
- https://doi.org/10.1016/j.clinthera.2007.02.008
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trialAmerican Heart Journal, 2006
- Statin Safety: A Systematic ReviewThe American Journal of Cardiology, 2006
- Statin Safety and Drug Interactions: Clinical ImplicationsThe American Journal of Cardiology, 2006
- Statin-related adverse events: A meta-analysisClinical Therapeutics, 2006
- Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin TherapyJournal of the American College of Cardiology, 2005
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary DiseaseNew England Journal of Medicine, 2005
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- Statin-Associated MyopathyJAMA, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001